Picture of Jenburkt Pharmaceuticals logo

524731 Jenburkt Pharmaceuticals Income Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Annual income statement for Jenburkt Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IAS
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue1,2261,1891,0931,2401,367
Cost of Revenue
Gross Profit8508477849131,022
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses9901,0149159861,086
Operating Profit236174178254281
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes266211216299329
Provision for Income Taxes
Net Income After Taxes198149165223246
Net Income Before Extraordinary Items
Net Income198149165223246
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income198149165223246
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS43.232.43648.355.7
Dividends per Share